39,90EUR | +0,90 EUR | +2,31 %
DAX-0,41 % EUR/USD-0,04 % Gold-0,22 % Öl (Brent)-0,86 %

Precision BioSciences (DTIL) - Genome Editing

ISIN: US74019P1084 | WKN: A2PGA1 | Symbol: DTIL
Baader Bank
-6,25 %
-0,525 EUR

Neuigkeiten zur Precision BioSciences Aktie

Beitrag schreiben

Begriffe und/oder Benutzer


Corporate Profile
Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.

Genome Editing Firm Precision BioSciences Prices $126.4M IPO
Mar 28, 2019
Precision BioSciences | 13,93 $

Beitrag zu dieser Diskussion schreiben